Skip to main content

Aeterna Zentaris(AEZS-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Aeterna Zentaris Announces Notice of Allowance for U.S. Patent Covering AEZS-150 for the Potential Treatment of Chronic Hypoparathyroidism

Globe Newswire - Wed Mar 2, 2022

Notice of allowance received by Company’s licensor, The University of Sheffield (UK) bolsters intellectual property ofAEZS-150 in development for the potential treatment of chronic hypoparathyroidism

Read more at globenewswire.com

Provided Content: Content provided by Globe Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.

More from The Globe